---
figid: PMC7576355__OTT-13-10499-g0005
figtitle: FGFR axis, Ras-Raf-MEK and TP53 relationship to CDK4/6; FGFR results in
  activation of PI3K, Ras-Raf-MEK, STAT which increases cyclin D1, thereby promoting
  progression through the cell cycle
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7576355
filename: OTT-13-10499-g0005.jpg
figlink: pmc/articles/PMC7576355/figure/f0005/
number: F5
caption: FGFR axis, Ras-Raf-MEK and TP53 relationship to CDK4/6; FGFR results in activation
  of PI3K, Ras-Raf-MEK, STAT which increases cyclin D1, thereby promoting progression
  through the cell cycle. The Ras-Raf-MEK pathway is needed for inactivation of tumor
  suppressor TP53 pathway. In addition, MDM2 also regulates p53 by proteasomal degradation.
  However, when the tumor suppressor, p53, is active it allows for activation of p21
  which regulates the cell cycle via CDK4/6 and CDK2 causing cell cycle arrest. RTK,
  receptor tyrosine kinase.
papertitle: Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant
  Prostate Cancer.
reftext: Adam M Kase, et al. Onco Targets Ther. 2020;13:10499-10513.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8227965
figid_alias: PMC7576355__F5
figtype: Figure
redirect_from: /figures/PMC7576355__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7576355__OTT-13-10499-g0005.html
  '@type': Dataset
  description: FGFR axis, Ras-Raf-MEK and TP53 relationship to CDK4/6; FGFR results
    in activation of PI3K, Ras-Raf-MEK, STAT which increases cyclin D1, thereby promoting
    progression through the cell cycle. The Ras-Raf-MEK pathway is needed for inactivation
    of tumor suppressor TP53 pathway. In addition, MDM2 also regulates p53 by proteasomal
    degradation. However, when the tumor suppressor, p53, is active it allows for
    activation of p21 which regulates the cell cycle via CDK4/6 and CDK2 causing cell
    cycle arrest. RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Trp53
  - Mdm2
  - ras
  - Hras
  - Kras
  - Rem1
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Mdk
  - Cdk4
  - Akt1
  - Pik3r1
  - Cdk2
  - Cle
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - TP53
  - MDM2
  - KRAS
  - HRAS
  - NRAS
  - TP63
  - TP73
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - CDK4
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CDK2
  - CCNE1
  - CCNE2
  - EIF2B5
  - RTRAF
  - btl
  - htl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Tie
  - Ras85D
  - InR
  - RyR
  - Ras64B
  - p53
  - betaTub60D
  - hth
  - dap
  - Dsor1
  - Mtk
  - Stat92E
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CycE
  - Erdafitinib
  - futibatinib
  - AZD4547
  - Trametinib
  - APR
  - diarrhea
  - dry mouth
  - fatigue
  - Dizziness
  - confusion
  - headache
---
